News Detail
New Delhi, 16 July 2024: The Supreme Court on Monday upheld the National Pharmaceutical Pricing Authority’s (NPPA) decision to recover Rs 4.65 crore including interest towards excess price charged by Sun Pharmaceuticals for Roscilox, a brand of a Cloxacillin-based drug form......
View Details
Source : Economic Times
Sun Pharma news
Supreme Court
Sun Pharma
Sun Pharma latest
Sun Pharma latest news
excess price charged
National Pharmaceutical Pricing Authority
DPCO
Roscilox
Related News
- Yeida to hire consultant for medical devices park (17-07-2024)
- Medical devices import grows 13 per cent in 2023-24 (17-07-2024)
- CCPA slaps Rs 10 lakh fine on firm selling ayurvedic oil through ‘misleading’ advertisements (17-07-2024)
- Fake cancer drugs case: Accused worked for top hospitals, eight patients traced: Delhi Police (17-07-2024)
- Focus on 113 home-grown, affordable medical devices to cut down import dependence, says govt (16-07-2024)
- Health ministry to amend D&C Rules to include excipient details on labels (16-07-2024)
- Telangana DCA files case against HP based drug manufacturer for DPCO violations (16-07-2024)
- First toll-free national anti-narcotics helpline to be launched (16-07-2024)
- Orthopaedic implants worth ₹70L seized by FDA (16-07-2024)
- Centre frames draft rules for compounding of offences under Drugs & Cosmetics Act (15-07-2024)